🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Duopharma Biotech Berhad (KLSE:DPHARMA)
Malaysia flag Malaysia · Delayed Price · Currency is MYR
1.030
-0.050 (-4.63%)
At close: Nov 20, 2026

Duopharma Biotech Berhad Income Statement

Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
916.98931.69813.7704.73696.72639.18
Revenue Growth
1.81%14.50%15.46%1.15%9.00%12.16%
Cost of Revenue
522.96568.56512.16436.4416.9385.19
Gross Profit
394.01363.14301.54268.33279.82253.98
Selling, General & Admin
232.61226.65202.02182.72186.59165.78
Other Operating Expenses
2.532.170.72.80.81-0.67
Operating Expenses
235.67229.36201.28189.61186.91165.22
Operating Income
158.34133.78100.2678.7192.9188.77
Interest Expense
-22.43-24.16-25.77-17.68-9.1-6.44
Interest & Investment Income
5.875.875.972.751.521.2
Other Non Operating Income (Expenses)
-0.5-0.59-0.82-0.52-0.48-0.53
EBT Excluding Unusual Items
141.29114.979.6363.2784.8582.99
Gain (Loss) on Sale of Assets
0.010.010.39---0.01
Pretax Income
141.3114.9180.0263.2784.8582.98
Income Tax Expense
33.6827.4517.3810.6214.7417.3
Net Income
107.6187.4662.6552.6570.1165.68
Net Income to Common
107.6187.4662.6552.6570.1165.68
Net Income Growth
28.88%39.62%19.00%-24.91%6.74%12.07%
Shares Outstanding (Basic)
961962962959948928
Shares Outstanding (Diluted)
961962962959948928
Shares Change
-0.01%-0.36%1.08%2.15%0.02%
EPS (Basic)
0.110.090.070.050.070.07
EPS (Diluted)
0.110.090.070.050.070.07
EPS Growth
28.89%39.62%18.57%-25.71%4.50%12.05%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
78.7279.9959.7715.865.08-66.16
Free Cash Flow Per Share
0.080.080.060.020.01-0.07
Dividend Per Share
0.0450.0450.0300.0230.0230.022
Dividend Growth
127.50%51.67%30.44%0%5.75%-55.43%
Gross Margin
42.97%38.98%37.06%38.07%40.16%39.74%
Operating Margin
17.27%14.36%12.32%11.17%13.33%13.89%
Profit Margin
11.74%9.39%7.70%7.47%10.06%10.28%
Free Cash Flow Margin
8.58%8.59%7.35%2.25%0.73%-10.35%
EBITDA
194.45171.05137.34114.04122.86114.94
EBITDA Margin
21.20%18.36%16.88%16.18%17.63%17.98%
D&A For EBITDA
36.1137.2737.0835.3229.9526.18
EBIT
158.34133.78100.2678.7192.9188.77
EBIT Margin
17.27%14.36%12.32%11.17%13.33%13.89%
Effective Tax Rate
23.84%23.89%21.72%16.79%17.37%20.85%